PERSONALIZING INJECTIONS WITH autoject®2
We’ll meet you wherever you are in your experience. Select your path below.
It’s important to know how to inject, when to inject, and where to inject. Call Teva’s Shared Solutions® now at 1-800-887-8100 or visit MySharedSolutions.com to schedule your free 1-on-1 injection training.
Switching to COPAXONE® 40 mg
Not yet comfortable with manual injections?
The autoject®2 for glass syringe can be a helpful tool. This automatic injection device hides the needle, allowing you to administer COPAXONE® at the touch of a button. And it’s available free of charge to anyone taking Teva’s COPAXONE® with a doctor’s prescription. Order yours through Teva’s Shared Solutions®.
Both 3-times-a-week COPAXONE® 40 mg and daily COPAXONE® 20 mg are given just under the skin (subcutaneously). They can be administered with the autoject®2 for glass syringe or administered manually.1
Ready for fewer injections?
Ask your doctor about 3-times-a-week COPAXONE® 40 mg. It can be administered with the autoject®2 for glass syringe or administered manually.1
With 3-times-a-week COPAXONE® 40 mg, you’re in control of your MS therapy ROUTINE.1
Choose a consistent (approximately the same time and on the same days each week) 3-times-a-week schedule that works for you (example: Monday, Wednesday, and Friday); injections must be at least 48 hours apart.1
3-times-a-week COPAXONE® 40 mg and daily COPAXONE® 20 mg are not interchangeable. COPAXONE® 40 mg is started 1-2 days after your last dose of COPAXONE® 20 mg.1,2
Watch our COPAXONE® injection video for step-by-step instructions:
Wherever you are in your therapy experience, training matters.
Even if you have used an injectable therapy before, you should be trained by a doctor or nurse before injecting COPAXONE® for the first time. Call Teva’s Shared Solutions® at 1-800-887-8100 or visit MySharedSolutions.com to schedule free 1-on-1 injection training when you start COPAXONE® therapy.
COPAXONE® (glatiramer acetate injection) Current Prescribing Information Parsippany, NJ. Teva Neuroscience, Inc.
Switching disease modifying therapies in multiple sclerosis. Cleveland Clinic. Accessed July 13, 2021. https://my.clevelandclinic.org/departments/neurological/depts/multiple-sclerosis/ms-approaches/switching-disease-modifying-therapies